Uses and misuses of the new pharmacotherapy of obesity

Authors
Citation
Ga. Bray, Uses and misuses of the new pharmacotherapy of obesity, ANN MED, 31(1), 1999, pp. 1-3
Citations number
10
Categorie Soggetti
General & Internal Medicine","Medical Research General Topics
Journal title
ANNALS OF MEDICINE
ISSN journal
07853890 → ACNP
Volume
31
Issue
1
Year of publication
1999
Pages
1 - 3
Database
ISI
SICI code
0785-3890(199902)31:1<1:UAMOTN>2.0.ZU;2-D
Abstract
The worldwide epidemic of obesity has made the development of effective tre atment ever more urgent. Appropriate use of medication for the treatment of obesity may benefit patients at risk for developing diabetes, hypertension , coronary artery disease, osteoarthritis or gall bladder disease. In addit ion, with the appearance of very safe medications, short-term treatment for the relief of the stigma associated with obesity may also be valuable. The currently available medications for obesity work either by reducing fat di gestion or by acting on receptor systems in the brain. Both have potential side-effects, but may be useful alone or in combination. The expansion of k nowledge about the control of obesity offers the hope that many new agents will become available over the next decade.